Literature DB >> 17382469

Nogo-A is involved in secondary axonal degeneration of thalamus in hypertensive rats with focal cortical infarction.

Fang Wang1, Zhijian Liang, Qinghua Hou, Shihui Xing, Li Ling, Meixia He, Zhong Pei, Jinsheng Zeng.   

Abstract

We investigate whether Nogo-A is involved in the secondary axonal degeneration in the thalamus after distal middle cerebral artery occlusion (MCAO) in stroke-prone renovascular hypertensive rats (RHRSP). The expression of Nogo-A in ipsilateral ventroposterior nucleus (VPN) of the thalamus in RHRSP was observed at 1, 2 and 4 weeks after distal MCAO. In addition, intracerebroventricular infusion of NEP1-40, a Nogo-66 receptor (NgR) antagonist peptide, was administered starting 24 h after MCAO and continued for 1, 2 and 4 weeks, respectively. Axonal damage and regeneration were evaluated by analysis of the immunoreactivity (IR) of amyloid betaA4 precursor protein (APP), growth associated protein 43 (GAP-43) and microtubule associated protein 2 (MAP-2) in ipsilateral VPN of the thalamus at 1, 2 and 4 weeks after distal MCAO. Following ischemia, the expression of Nogo-A in oligodendrocytes increased persistently and its localization became redistributed around damaged axons and dendrites. Administration of NEP1-40 downregulated the expression of Nogo-A, reduced axonal injury and enhanced axonal regeneration. Our data suggest that Nogo-A is involved in secondary axonal degeneration and that inhibition of Nogo-A can reduce neuronal damage in the thalamus after distal MCAO.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17382469     DOI: 10.1016/j.neulet.2007.02.080

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  18 in total

1.  Combination treatment of experimental stroke with Niaspan and Simvastatin, reduces axonal damage and improves functional outcome.

Authors:  Amjad Shehadah; Jieli Chen; Xu Cui; Cynthia Roberts; Mei Lu; Michael Chopp
Journal:  J Neurol Sci       Date:  2010-05-07       Impact factor: 3.181

2.  Ultrastructure of Diaschisis Lesions after Traumatic Brain Injury.

Authors:  Clayton A Wiley; Stephanie J Bissel; Andrew Lesniak; C Edward Dixon; Jonathan Franks; Donna Beer Stolz; Ming Sun; Guoji Wang; Robert Switzer; Patrick M Kochanek; Geoffrey Murdoch
Journal:  J Neurotrauma       Date:  2016-03-30       Impact factor: 5.269

3.  EphrinB2 activation enhances angiogenesis, reduces amyloid-β deposits and secondary damage in thalamus at the early stage after cortical infarction in hypertensive rats.

Authors:  Shihui Xing; Nannan Pan; Wei Xu; Jian Zhang; Jingjing Li; Chao Dang; Gang Liu; Zhong Pei; Jinsheng Zeng
Journal:  J Cereb Blood Flow Metab       Date:  2018-04-06       Impact factor: 6.200

4.  Comparison of RNAi NgR and NEP1-40 in Acting on Axonal Regeneration After Spinal Cord Injury in Rat Models.

Authors:  Jing Xu; Jian He; Huang He; Renjun Peng; Jian Xi
Journal:  Mol Neurobiol       Date:  2016-12-05       Impact factor: 5.590

5.  Reduction of β-amyloid deposits by γ-secretase inhibitor is associated with the attenuation of secondary damage in the ipsilateral thalamus and sensory functional improvement after focal cortical infarction in hypertensive rats.

Authors:  Yusheng Zhang; Shihui Xing; Jian Zhang; Jingjing Li; Chuo Li; Zhong Pei; Jinsheng Zeng
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-04       Impact factor: 6.200

6.  Nogo-A/Pir-B/TrkB Signaling Pathway Activation Inhibits Neuronal Survival and Axonal Regeneration After Experimental Intracerebral Hemorrhage in Rats.

Authors:  Yinlong Liu; Chao Ma; Haiying Li; Haitao Shen; Xiang Li; Xi'an Fu; Jiang Wu; Gang Chen
Journal:  J Mol Neurosci       Date:  2019-07-08       Impact factor: 3.444

7.  The effect of an NgR1 antagonist on the neuroprotection of cortical axons after cortical infarction in rats.

Authors:  Hong Zhan; Shu-Jie Sun; Jie Cai; Ying-Qing Li; Chun-Lin Hu; Daniel H S Lee; Kwok-Fai So; Xin Li
Journal:  Neurochem Res       Date:  2013-03-24       Impact factor: 3.996

8.  The neurorestorative benefit of GW3965 treatment of stroke in mice.

Authors:  Xu Cui; Michael Chopp; Alex Zacharek; Yisheng Cui; Cynthia Roberts; Jieli Chen
Journal:  Stroke       Date:  2012-11-29       Impact factor: 7.914

Review 9.  Impact of Comorbidities on Acute Injury and Recovery in Preclinical Stroke Research: Focus on Hypertension and Diabetes.

Authors:  Adviye Ergul; Sherif Hafez; Abdelrahman Fouda; Susan C Fagan
Journal:  Transl Stroke Res       Date:  2016-03-30       Impact factor: 6.829

10.  Targeted drug delivery to ischemic stroke via chlorotoxin-anchored, lexiscan-loaded nanoparticles.

Authors:  Liang Han; Qiang Cai; Daofeng Tian; Derek K Kong; Xingchun Gou; Zeming Chen; Stephen M Strittmatter; Zuoheng Wang; Kevin N Sheth; Jiangbing Zhou
Journal:  Nanomedicine       Date:  2016-03-30       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.